Neurocrine Biosciences, Inc (NASDAQ: NBIX) is -5.15% lower on its value in year-to-date trading and has touched a low of $84.23 and a high of $157.98 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NBIX stock was last observed hovering at around $133.51 in the last trading session, with the day’s gains setting it 1.41%.
Currently trading at $134.92, the stock is 5.88% and 9.99% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.05 million and changing 1.06% at the moment leaves the stock 10.81% off its SMA200. NBIX registered -1.16% loss for a year compared to 6-month loss of -1.41%. The firm has a 50-day simple moving average (SMA 50) of $122.662 and a 200-day simple moving average (SMA200) of $121.7588.
The stock witnessed a 7.31% gain in the last 1 month and extending the period to 3 months gives it a 54.12%, and is 4.27% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.26% over the week and 2.20% over the month.
Neurocrine Biosciences, Inc (NBIX) has around 1800 employees, a market worth around $13.35B and $2.41B in sales. Current P/E ratio is 45.75 and Fwd P/E is 22.77. Profit margin for the company is 12.68%. Distance from 52-week low is 60.18% and -14.60% from its 52-week high. The company has generated returns on investments over the last 12 months (10.25%).
The EPS is expected to grow by 18.51% this year
882.0 institutions hold shares in Neurocrine Biosciences, Inc (NBIX), with institutional investors hold 99.72% of the company’s shares. The shares outstanding are 99.00M, and float is at 95.47M with Short Float at 3.66%. Institutions hold 98.66% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 14.19 million shares valued at $1.95 billion. The investor’s holdings represent 14.0781 of the NBIX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.06 million shares valued at $1.38 billion to account for 9.9766 of the shares outstanding. The other top investors are STATE STREET CORP which holds 4.61 million shares representing 4.5718 and valued at over $634.43 million, while RENAISSANCE TECHNOLOGIES LLC holds 2.4486 of the shares totaling 2.47 million with a market value of $339.79 million.
Neurocrine Biosciences, Inc (NBIX) Insider Activity
Neurocrine Biosciences, Inc disclosed in a document filed with the SEC on Jul 02 ’25 that Onyia Jude (Chief Scientific Officer) sold a total of 20,362 shares of the company’s common stock. The trade occurred on Jul 02 ’25 and was made at $130.13 per share for $2.65 million. Following the transaction, the insider now directly holds 18289.0 shares of the NBIX stock.
